Beyond BMI: The "metabolically healthy obese" phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality - A systematic review

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Roberson, Lara L ^a   Aneni, Ehimen C ^a   Maziak, Wasim ^c   Agatston, Arthur ^a   Feldman, Theodore ^a   Rouseff, Maribeth ^b   Tran, Thinh ^b   Blaha, Michael J ^d   Santos, Raul D ^e   Sposito, Andrei ^f   Al Mallah, Mouaz H ^g   Blankstein, Ron ^h   Budoff, Matthew J ⁱ   Nasir, Khurram ^a,c,d,j  

^a Baptist Health South Florida   (United States)

^b MIAMI CANCER INSTITUTE   (United States)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF CAMPINAS   (Brazil)

^g KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^j FLORIDA INTERNATIONAL UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL WALL THICKNESS; BODY MASS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMPLICATION; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MORTALITY; OBESITY; PHENOTYPE; RISK FACTOR;

BODY MASS INDEX; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CAUSE OF DEATH; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY; PHENOTYPE; RISK FACTORS;

EID: 84892172233     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-14     Document Type: Article

References (47)

1. World Health Statistics 2012, World Health Organization 20 Avenue Appia, 1211 Geneva 27, Switzerland: WHO Press 2012 Retrieved February 12, 2013 from http://www.who.int/gho/publications/world-health-statistics/2012/en/
2. Prevalence of obesity in the United States, 2009-2010. Ogden CL, Carroll MD, Kit BK, Flegal KM, NCHS data brief 2012 82 1 8 22617494
3. Obesity and mortality: a review of the epidemiologic data. Solomon CG, Manson JE, Am J Clin Nutr 1997 66 4 Suppl 1044S 1050S 9322585 (Pubitemid 27418746)
4. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. Flegal KM, Kit BK, Orpana H, Graubard BI, JAMA 2013 309 1 71 82 10.1001/jama.2012.113905 23280227
5. Annual medical spending attributable to obesity: payer-and service-specific estimates. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W, Health Aff (Millwood) 2009 28 5 822 w831 10.1377/hlthaff.28.5.w822 19635784
6. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Bluher M, Curr Opin Lipidol 2010 21 1 38 43 10.1097/MOL. 0b013e3283346ccc 19915462
7. To be obese-does it matter if you are metabolically healthy? Karelis AD, Nat Rev Endocrinol 2011 7 12 699 700 10.1038/nrendo.2011.181 22009160
8. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the us population (nhanes 1999-2004). Wildman RP, Muntner P, Reynolds K, et al. Arch Intern Med 2008 168 15 1617 1624 10.1001/archinte.168. 15.1617 18695075
9. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Arnlov J, Ingelsson E, Sundstrom J, Lind L, Circulation 2010 121 2 230 236 10.1161/CIRCULATIONAHA.109. 887521 20038741
10. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M, Mannino S, Crosignani P, Bosi E, Luzi L, et al. Diabetes Care 2011 34 1 210 215 10.2337/dc10-0665 20937689
11. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. Hamer M, Stamatakis E, J Clin Endocrinol Metab 2012 97 7 2482 2488 10.1210/jc.2011-3475 22508708
12. Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS). Hosseinpanah F, Barzin M, Sheikholeslami F, Azizi F, Am J Cardiol 2011 107 3 412 416 10.1016/j.amjcard.2010.09.034 21257007
13. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Kuk JL, Ardern CI, Diabetes Care 2009 32 12 2297 2299 10.2337/dc09-0574 19729521
14. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D'Agostino RB, J Clin Endocrinol Metab 2006 91 8 2906 2912 10.1210/jc.2006-0594 16735483 (Pubitemid 44271734)
15. Incident cardiovascular disease events in metabolically benign obese individuals. Ogorodnikova AD, Kim M, McGinn AP, Muntner P, Khan U, Wildman RP, Obesity (Silver Spring) 2012 20 3 651 659 10.1038/oby.2011.243 21799477
16. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS, Blair SN, Eur Heart J 2013 34 5 389 397 10.1093/eurheartj/ehs174 22947612
17. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. St-Pierre AC, Cantin B, Mauriege P, Bergeron J, Dagenais GR, Despres JP, Lamarche B, CMAJ 2005 172 10 1301 1305 10.1503/cmaj.1040834 15883404 (Pubitemid 40745071)
18. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. Voulgari C, Tentolouris N, Dilaveris P, Tousoulis D, Katsilambros N, Stefanadis C, J Am Coll Cardiol 2011 58 13 1343 1350 10.1016/j.jacc.2011.04.047 21920263
19. Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Katzmarzyk PT, Church TS, Janssen I, Ross R, Blair SN, Diabetes Care 2005 28 2 391 397 10.2337/diacare.28.2.391 15677798 (Pubitemid 40170945)
20. Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial. Daly CA, Hildebrandt P, Bertrand M, Ferrari R, Remme W, Simoons M, Fox KM, Heart 2007 93 11 1406 1411 10.1136/hrt.2006.113084 17540689 (Pubitemid 351480141)
21. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Song Y, Manson JE, Meigs JB, Ridker PM, Buring JE, Liu S, Am J Cardiol 2007 100 11 1654 1658 10.1016/j.amjcard.2007.06.073 18036364 (Pubitemid 350130235)
22. Prognostic implications for insulin-sensitive and insulin-resistant normal-weight and obese individuals from a population-based cohort. Bo S, Musso G, Gambino R, Villois P, Gentile L, Durazzo M, Cavallo-Perin P, Cassader M, Am J Clin Nutr 2012 96 5 962 969 10.3945/ajcn.112.040006 23034958
23. From metabolic normality to cardiometabolic risk factors in subjects with obesity. Bobbioni-Harsch E, Pataky Z, Makoundou V, Laville M, Disse E, Anderwald C, Konrad T, Golay A, Obesity (Silver Spring) 2012 20 10 2063 2069 10.1038/oby.2012.69 22421925
24. Does inflammation determine whether obesity is metabolically healthy or unhealthy? Alam I, Ng TP, Larbi A, Aging Perspect Mediat Inflamm 2012 2012 14
25. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, Lauro R, Perticone F, Sesti G, Diabetes Care 2007 30 8 2145 2147 10.2337/dc07-0419 17507694 (Pubitemid 47219439)
26. Identification and characterization of metabolically benign obesity in humans. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Haring HU, Arch Intern Med 2008 168 15 1609 1616 10.1001/archinte.168.15.1609 18695074
27. Burden of subclinical cardiovascular disease in metabolically benign and at-risk overweight and obese women: the Study of Women's Health Across the Nation (SWAN). Khan UI, Wang D, Thurston RC, Sowers M, Sutton-Tyrrell K, Matthews KA, Barinas-Mitchell E, Wildman RP, Atherosclerosis 2011 217 1 179 186 10.1016/j.atherosclerosis.2011.01.007 21310415
28. Obesity phenotype and cardiovascular changes. Park J, Kim SH, Cho GY, Baik I, Kim NH, Lim HE, Kim EJ, Park CG, Lim SY, Kim YH, et al. J Hypertens 2011 29 9 1765 1772 10.1097/HJH.0b013e32834a50f3 21826021
29. Body mass index, metabolic syndrome and carotid atherosclerosis. Irace C, Scavelli F, Carallo C, Serra R, Cortese C, Gnasso A, Coron Artery Dis 2009 20 2 94 99 10.1097/MCA.0b013e3283219e76 19293666
30. Are there persons who are obese, but metabolically healthy? Sims EA, Metabolism 2001 50 12 1499 1504 10.1053/meta.2001.27213 11735101 (Pubitemid 34007425)
31. Point: visceral adiposity is causally related to insulin resistance. Lebovitz HE, Banerji MA, Diabetes Care 2005 28 9 2322 2325 10.2337/diacare.28.9. 2322 16123512 (Pubitemid 41242490)
32. The pros and cons of diagnosing diabetes with A1C. Bonora E, Tuomilehto J, Diabetes Care 2011 34 Suppl 2 184 S190 21525453
33. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Muniyappa R, Lee S, Chen H, Quon MJ, Am J Physiol Endocrinol Metab 2008 294 1 15 E26 17957034
34. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B, Eur Cytokine Netw 2006 17 1 4 12 16613757
35. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander? Nordestgaard BG, Zacho J, Nutr Metab Cardiovasc Dis 2009 19 8 521 524 10.1016/j.numecd.2009.07.005 19695857
36. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Moore JB, Proc Nutr Soc 2010 69 2 211 220 10.1017/S0029665110000030 20158939
37. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. Targher G, Day CP, Bonora E, N Engl J Med 2010 363 14 1341 1350 10.1056/NEJMra0912063 20879883
38. Metabolically healthy but obese individuals: relationship with hepatic enzymes. Messier V, Karelis AD, Robillard ME, Bellefeuille P, Brochu M, Lavoie JM, Rabasa-Lhoret R, Metabolism 2010 59 1 20 24 10.1016/j.metabol.2009.06.020 19709695
39. Metabolic syndrome and insulin resistance in subjects with morbid obesity. Soverini V, Moscatiello S, Villanova N, Ragni E, Di Domizio S, Marchesini G, Obes Surg 2010 20 3 295 301 10.1007/s11695-009-9999-z 19841991
40. Changing trends in the prevalence and disparities of obesity and other cardiovascular disease risk factors in three racial/ethnic groups of USA adults. Romero CX, Romero TE, Shlay JC, Ogden LG, Dabelea D, Adv Prev Med 2012 2012 172423 23243516
41. State of disparities in cardiovascular health in the United States. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB, Circulation 2005 111 10 1233 1241 10.1161/01.CIR.0000158136.76824.04 15769763 (Pubitemid 40389086)
42. Diet composition and activity level of at risk and metabolically healthy obese American adults. Hankinson AL, Daviglus ML, Van Horn L, Chan Q, Brown I, Holmes E, Elliott P, Stamler J, Obesity (Silver Spring) 2012 21 3 637 643
43. Physical activity, fitness and cardiovascular disease risk in adults: interactions with insulin resistance and obesity. Gill JM, Malkova D, Clin Sci (Lond) 2006 110 4 409 425 10.1042/CS20050207 16526946
44. Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. Wilmot EG, Edwardson CL, Achana FA, Davies MJ, Gorely T, Gray LJ, Khunti K, Yates T, Biddle SJ, Diabetologia 2012 55 11 2895 2905 10.1007/s00125-012-2677-z 22890825
45. Obesity: a major component of the metabolic syndrome. Nesto RW, Texas Heart Institute journal / from the Texas Heart Institute of St Luke's Episcopal Hospital, Texas Children's Hospital 2005 32 3 387 389 (Pubitemid 41306802)
46. Brd2 Gene disruption causes metabolically healthy obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes. Wang F, Deeney JT, Denis GV, Vitam Horm 2013 91 49 75 23374712
47. Obesity: the integrated roles of environment and genetics. Speakman JR, J Nutr 2004 134 8 Suppl 2090S 2105S 15284410 (Pubitemid 39031287)